Osimertinib resistance mechanisms in nonsmall cell lung cancer using focused CRISPR Screen: FOSL1 and JUN

Uluata-Dayanc B., ERİŞ S., Cakiroglu E., Ozden-Yilmaz G., Coskun-Deniz O. S., KARAKÜLAH G., ...More

FEBS OPEN BIO, vol.13, pp.149-150, 2023 (SCI-Expanded)

• Publication Type: Article / Abstract
• Volume: 13
• Publication Date: 2023
• Journal Name: FEBS OPEN BIO
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED)
• Page Numbers: pp.149-150
• Dokuz Eylül University Affiliated: Yes